These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11914043)

  • 1. IPF-1 gene variation and the development of type 2 diabetes.
    Silver K; Shetty A
    Mol Genet Metab; 2002 Mar; 75(3):287-9. PubMed ID: 11914043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in caucasians.
    Hansen L; Urioste S; Petersen HV; Jensen JN; Eiberg H; Barbetti F; Serup P; Hansen T; Pedersen O
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1323-6. PubMed ID: 10720084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin Promoter Factor 1 variation is associated with type 2 diabetes in African Americans.
    Karim MA; Wang X; Hale TC; Elbein SC
    BMC Med Genet; 2005 Oct; 6():37. PubMed ID: 16229747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the insulin promoter factor-1 gene in late-onset type 2 diabetes mellitus.
    Reis AF; Ye WZ; Dubois-Laforgue D; Bellanné-Chantelot C; Timsit J; Velho G
    Eur J Endocrinol; 2000 Oct; 143(4):511-3. PubMed ID: 11022198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense mutations in the human insulin promoter factor-1 gene are not a common cause of type 2 diabetes mellitus in Taiwan.
    Shiau MY; Huang CN; Liao JH; Chang YH
    J Endocrinol Invest; 2004 Dec; 27(11):1076-80. PubMed ID: 15754742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of the human LIM/homeodomain gene islet-1 and identification of a simple sequence repeat polymorphism [corrected].
    Tanizawa Y; Riggs AC; Dagogo-Jack S; Vaxillaire M; Froguel P; Liu L; Donis-Keller H; Permutt MA
    Diabetes; 1994 Jul; 43(7):935-41. PubMed ID: 7912209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes.
    Macfarlane WM; Frayling TM; Ellard S; Evans JC; Allen LI; Bulman MP; Ayres S; Shepherd M; Clark P; Millward A; Demaine A; Wilkin T; Docherty K; Hattersley AT
    J Clin Invest; 1999 Nov; 104(9):R33-9. PubMed ID: 10545530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte nuclear factor-6: associations between genetic variability and type II diabetes and between genetic variability and estimates of insulin secretion.
    Møller AM; Ek J; Durviaux SM; Urhammer SA; Clausen JO; Eiberg H; Hansen T; Rousseau GG; Lemaigre FP; Pedersen O
    Diabetologia; 1999 Aug; 42(8):1011-6. PubMed ID: 10491763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of FOXO1A as a candidate gene for type 2 diabetes.
    Karim MA; Craig RL; Wang X; Hale TC; Elbein SC
    Mol Genet Metab; 2006 Jun; 88(2):171-7. PubMed ID: 16497530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the aspartic acid to asparagine substitution at position 76 in the pancreas duodenum homeobox gene (PDX1) cause late-onset type 2 diabetes?
    Elbein SC; Karim MA
    Diabetes Care; 2004 Aug; 27(8):1968-73. PubMed ID: 15277425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy.
    Keene KL; Mychaleckyj JC; Smith SG; Leak TS; Perlegas PS; Langefeld CD; Freedman BI; Rich SS; Bowden DW; Sale MM
    Diabetes; 2008 Apr; 57(4):1057-62. PubMed ID: 18184924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations.
    Weng J; Macfarlane WM; Lehto M; Gu HF; Shepherd LM; Ivarsson SA; Wibell L; Smith T; Groop LC
    Diabetologia; 2001 Feb; 44(2):249-58. PubMed ID: 11270685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus.
    Hani EH; Stoffers DA; Chèvre JC; Durand E; Stanojevic V; Dina C; Habener JF; Froguel P
    J Clin Invest; 1999 Nov; 104(9):R41-8. PubMed ID: 10545531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of the thiopurine S-methyltransferase gene in African-Americans.
    Hon YY; Fessing MY; Pui CH; Relling MV; Krynetski EY; Evans WE
    Hum Mol Genet; 1999 Feb; 8(2):371-6. PubMed ID: 9931346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of sequence variants in the pre-B cell leukemia transcription factor 1 gene: a positional and functional candidate for type 2 diabetes and impaired insulin secretion.
    Wang H; Chu W; Wang X; Zhang Z; Elbein SC
    Mol Genet Metab; 2005 Nov; 86(3):384-91. PubMed ID: 16140554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of a proline insertion in the insulin promoter factor 1 (IPF1) gene in African Americans with type 2 diabetes.
    Elbein SC; Wang X; Karim MA; Freedman BI; Bowden DW; Shuldiner AR; Brancati FL; Kao WH
    Diabetes; 2006 Oct; 55(10):2909-14. PubMed ID: 17003361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin promoter factor 1 gene is not a major cause of maturity-onset diabetes of the young in French Caucasians.
    Chèvre JC; Hani EH; Stoffers DA; Habener JF; Froguel P
    Diabetes; 1998 May; 47(5):843-4. PubMed ID: 9588460
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of osteocalcin as a candidate gene for type 2 diabetes (T2D) and intermediate traits in Caucasians and African Americans.
    Das SK; Sharma NK; Elbein SC
    Dis Markers; 2010; 28(5):281-6. PubMed ID: 20592451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hep-G2 glucose transporter gene polymorphism in Caucasian, black, Hispanic and Japanese patients with NIDDM.
    Murakami K; Wilk J; Nishida K; Sussman KE; Draznin B
    Diabetes Res Clin Pract; 1990; 9(2):115-21. PubMed ID: 1973913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians.
    Vozarova B; Fernández-Real JM; Knowler WC; Gallart L; Hanson RL; Gruber JD; Ricart W; Vendrell J; Richart C; Tataranni PA; Wolford JK
    Hum Genet; 2003 Apr; 112(4):409-13. PubMed ID: 12589429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.